We didn't enter the wellness space.
We rejected it.
AnthologyRX was founded by four people who had quietly been using clinical longevity protocols and couldn't find a single company building them with any real credibility. So they built one.
The standard of care
shouldn't be a privilege.
Decline is not a diagnosis. It is a default. And defaults can be overridden. The human body is a dynamic system that responds to precise inputs, and the clinical tools available to support its function today are more sophisticated, more studied, and more accessible than at any point in medical history. The question has never been whether this medicine works. The question has been who gets access to it.
Until now, the answer was: the right people, in the right cities, with the right relationships. Concierge memberships that ran $30,000 a year. Private physicians who treated optimization as a luxury add-on. The compounds prescribed at AnthologyRX are the same ones those physicians have always used. Reviewed by licensed providers, compounded by licensed 503A pharmacies, managed with the same clinical rigor. What we changed is the gate. If you qualify, you're in.
Choosing clinical support for your longevity is not an indulgence. It is the natural extension of every evidence-based decision you already make. About training, nutrition, sleep, and recovery. Those choices are respected. This one should be too. AnthologyRX exists to make it clinically legitimate, provider-supervised, and. For the first time. Genuinely within reach.
"You can buy longevity and performance treatments anywhere. At Anthology, you're buying the will to aspire to your true potential."
Built by people
who use it.
Every founder at this table is an active patient. That's not marketing. That's the prerequisite.
Michael Eisman has spent his career building companies in industries that didn't yet have a playbook. And making them work anyway. At Apple, he absorbed what operational precision looks like at civilizational scale. At MedMen, he helped architect what the press called "the Apple Store of Weed". a nationally recognized cannabis retail brand that raised $150M and helped legitimize an entire category. When that chapter closed, he quietly took on a distressed B2B logistics company, wiped $2M in inherited debt, rebuilt it from the inside, and exited at 8x EBITDA.
He founded Echelon Agency in Los Angeles. a talent management firm at the intersection of elite fitness culture and the creator economy. That vantage point gave him an early signal: the people performing at the highest levels were quietly using clinical longevity protocols to sustain it. NAD+. Peptides. Metabolic optimization. Not as a secret. As a discipline. But the category had no credible consumer-facing infrastructure. No trusted front door. Michael decided to build one.
He is a personal patient of the protocols AnthologyRX offers. This was never a market thesis first. It was a daily reality that demanded a company.
Danika Lane Wignall has spent a decade doing the thing most people find hardest: walking into rooms where no one knows her name and walking out with a signed contract. As National Director of Sales and now VP of Sales and Marketing at Pegasus, she built and led revenue operations across one of the most demanding B2B environments in the country. Facilities serving pharmaceutical manufacturers, biotech labs, and aerospace companies where the margin for error is zero and the sales cycle tests your conviction. Before that, she closed complex multi-year contracts at Controlled Contamination Services, covering Los Angeles, the Inland Empire, and Orange County. She knows how to build a pipeline. She knows how to close.
What that background produces is not a title. It is a set of instincts: how to earn trust in a category where skepticism is the default, how to turn a first conversation into a long-term relationship, how to build commercial systems that scale. Clinical longevity medicine is a high-trust, high-consideration purchase. The person deciding to start a longevity protocol or commit to a precision health program is not making an impulse decision. Danika understands that patient. And knows exactly how to meet them.
As Chief Revenue Officer, she is responsible for the commercial infrastructure that turns a compelling brand into a growing business: the partnerships, the patient acquisition strategy, and the revenue systems that make growth repeatable.
Dr. Dylan Russell's credentials are not decorative. He graduated from West Point with a degree in Life Sciences and Chemistry, earned his MD from the University of Virginia School of Medicine, and spent seven years completing his surgical residency with the United States Army. He currently serves as a General Surgeon with the U.S. Army Medical Department.
His path through military medicine has given him an unusually clear view of what late-stage metabolic decline actually produces. The cardiovascular deterioration. The interventions that arrive twenty years too late. Dr. Russell's belief in prevention is not a philosophy. It is a clinical conclusion drawn from direct observation. Prevention is not the alternative to serious medicine. It is the most serious medicine available.
As Chief Health Officer, he sets the standard that every AnthologyRX protocol must meet: the same bar he would apply to his own patients, and to himself. Every compound we offer is reviewed through that lens. Nothing ships without it.
Dave Schenk has spent over two decades in the study and practice of human performance. He was a Division I wrestler at Cal Poly San Luis Obispo, team captain and conference champion at 197 lbs. He went on to build and run multiple performance facilities across Southern California, earning credentials from ACE, NASM, and the National Strength and Conditioning Association. He is a Certified Strength and Conditioning Specialist, an international presenter at ASIAFIT in Shanghai, and the founder of Iron Anthology in Los Angeles.
What twenty years of coaching produces is not a philosophy. It is a set of observations about what the body does over time, even when you do everything right. Hormonal output shifts. Recovery extends. The tools that worked at 30 require reinforcement at 45. Dave came to clinical longevity medicine the same way serious athletes come to everything: methodically, with a standard, and with the expectation that the science has to be as rigorous as the training.
As Chief Brand Officer, he brings that standard to how AnthologyRX presents itself to the world. The brand he represents is one he has earned the right to represent.
Every protocol at AnthologyRX is reviewed under the medical oversight of Dr. Dylan Russell, MD, Chief Health Officer, before a single prescription is issued. No treatment ships without qualified provider approval. All compounds are prepared by licensed, 503A compounding pharmacies. Clinical credibility is not a feature we added. It is the foundation we built on.
"You can buy longevity and performance treatments anywhere.
At Anthology, you're buying the will to aspire to your true potential."
Michael Eisman, Chief Executive Officer
The first step is straightforward.
Complete a brief health assessment. A licensed provider reviews your intake within 48 hours. If approved, your protocol ships directly to your door. No waiting rooms, no gatekeepers.